Literature DB >> 4599389

Immune complex disease in experimental animals and man.

C G Cochrane, D Koffler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4599389     DOI: 10.1016/s0065-2776(08)60298-9

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  154 in total

Review 1.  Antihistamines: pharmacology and clinical use.

Authors:  D S Pearlman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin.

Authors:  M Torbinejad; J Clagett; D Engel
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

3.  Computer simulation of immunochemical interactions.

Authors:  J Steensgaard; H K Johansen; N P Moller
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

4.  Attempts to induce immune-mediated cerebral arterial injury for an experimental model of moyamoya disease.

Authors:  M Ezura; S Fujiwara; M Nose; T Yoshimoto; M Kyogoku
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

5.  Immunopathology of the lung: a review.

Authors:  K J Johnson; W E Chapman; P A Ward
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

Review 6.  Role of circulating soluble immune complexes in disease.

Authors:  R J Levinsky
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

7.  Immune complexes and complement hypercatabolism in patients with leprosy.

Authors:  B Bjorvatn; R S Barnetson; G Kronvall; R H Zubler; P H Lambert
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

Review 8.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

9.  Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).

Authors:  D Chia; E V Barnett; J Yamagata; D Knutson; C Restivo; D Furst
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

10.  DNA binding activity of serum from patients with systemic lupus erythematosus.

Authors:  J F Halsey; W A Woolery; S Oleinick; M B Kahaleh; E C Leroy
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.